Besunyen Holdings Co. Ltd.

Besunyen Holdings Co. Ltd.

HHKEX:926
2.35
HKD
0.00
(0.00%)
297.11MMarket Cap
Besunyen Holdings Co. Ltd.
HKEX:926
(Hong Kong Exchange)

Recent

price

2.35

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
18.53
13.52
8.22
8.66
9.97
11.71
9.25
9.73
6.42
13.78
21.93
18.67
14.27
4.44
3.96
4.04
- -
Revenue per Share
1.26
-0.66
-5.92
-1.6
0.8
1.63
-1.23
0.07
-1.62
2.75
0.77
-2.47
-1.76
-2.45
0.12
0.17
- -
Basic EPS, GAAP
0.57
-8.35
-1.05
-0.48
0.97
0.42
-1.42
-0.57
-2.06
-1.51
-0.84
-4.74
0.17
0.03
0.05
0.45
- -
Free Cash Flow per Basic Share
1.01
0.67
- -
- -
0.28
0.7
2.3
- -
- -
2.68
- -
0.84
- -
- -
0.81
0.23
- -
Dividend per Share
27.94
26.86
21.3
19.85
20.4
21.41
18.07
17.58
16
16.08
16.83
13.74
6.99
4.53
3.89
3.83
3.95
Book Value per Share
27.25
26.5
21.22
19.81
13.87
14.73
17.92
8.52
10.92
11.44
12.51
9.91
5.32
4.37
3.74
3.69
3.82
Tangible Book Value per Share
47
62
58
56
57
57
56
56
59
59
59
59
56
122
122
122
122
Basic Weighted Avg Shares
874
840
475
488
564
663
515
543
378
812
1,293
1,101
801
543
484
494
- -
Sales/Revenue/Turnover
11.57
-0.44
-61.02
-17.88
3.91
6.66
-15.23
-4.98
-32.81
-1.74
2.95
-8.38
-3.43
-28.57
2.11
6.47
- -
Operating Margin (%)
20
34
39
45
43
41
45
47
60
55
56
79
33
24
18
20
- -
Depreciation Expense
60
-41
-342
-90
45
92
-69
4
-95
162
45
-146
-99
-299
15
20
- -
Net Income, GAAP
41.02
- -
- -
- -
17.38
- -
- -
- -
- -
2.57
- -
- -
- -
- -
46.21
36.41
- -
Effective Tax Rate (%)
6.82
-4.86
-72.01
-18.46
7.99
13.92
-13.35
0.75
-25.19
19.99
3.52
-13.23
-12.37
-55.12
3.06
4.14
- -
Profit Margin (%)
1,306
833
417
341
373
383
87
90
310
509
563
229
393
282
156
178
203
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
36
75
115
61
2
2
2
2
LT Debt
1,736
1,672
1,236
1,151
1,183
1,246
990
1,142
1,049
1,079
1,210
1,055
1,052
554
475
468
483
Total Equity
5.6
- -
- -
- -
1.41
- -
- -
- -
- -
16.87
- -
- -
- -
- -
2.2
3.6
- -
Return on Invested Capital (%)
5.68
- -
- -
- -
3.86
- -
- -
- -
- -
11.79
- -
- -
- -
- -
2.87
4.33
- -
Return on Capital (%)
5.86
-2.4
-23.54
-7.54
3.86
7.62
-6.16
0.4
-9.42
16.8
4.59
-15.82
-11.78
-42.5
2.88
4.33
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
2
3
4
LT Borrowings
- -
- -
- -
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
122
122
122
Market Capitalization
280
263
257

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
280
268
322
Cash, Cash Equivalents & STI
165
178
219
Accounts Receivable, Net
31
28
31
Inventories
28
29
29
Total Current Liabilities
100
90
119
Payables & Accruals
- -
- -
- -
ST Debt
2
3
4
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-7.44%
-15.23%
-1.5%
Free Cash Flow
97.37%
249.89%
884.05%
Net Income, GAAP
-337.23%
-63.45%
38.09%
Sales/Revenue/Turnover
4.36%
-16.6%
2.07%
Total Cash Common Dividend
- -
- -
-72.03%

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
484
2025
- -
- -
494
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.12
2025
- -
- -
0.17
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.81
2025
- -
- -
0.23
2026
- -
- -
- -
Business
Besunyen Holdings Company Limited engages in the development, manufacture, promotion, and distribution of functional health teas and pharmaceutical products primarily across the People's Republic of China and internationally. The company offers a diverse range of wellness teas, including its widely recognized Besunyen Detox Tea and Besunyen Slimming Tea, alongside options like Besunyen Fit Tea, Besunyen Relief Tea, and other specialized herbal formulations. Additionally, it provides over-the-counter (OTC) medications such as Besunyen Orlistat weight-loss capsules, complemented by nutritional meal replacements, probiotics, and enzymes. Products reach consumers through a comprehensive network encompassing OTC pharmacies, various retail outlets including shopping malls and supermarkets, an extensive distributor and sub-distributor system, and robust e-commerce platforms. Established in 2000, Besunyen Holdings Company Limited maintains its principal office in Central, Hong Kong, and operates as a subsidiary of Foreshore Holding Group Limited.